ASE Test, Inc. 的 Form 4 申報
Ainos, Inc.（AIMD），2026/4/15 申報
- 申報編號
- 0000950103-26-005723
- 申報時間
- 2026/4/15
- 交易日
- 2026/4/12
- 申報延遲
- 3 天遲報
- 10b5-1 計畫
- 沒有勾選
這份申報列了 1 筆衍生性交易。交易後 3 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| ASE Test, Inc.CIK 0002021793 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
As previously reported, the Issuer and ASE Test, Inc. entered into a Convertible Note and Warrant Purchase Agreement, dated March 13, 2023 (the "2023 Convertible Note"), pursuant to which the Issuer issued convertible promissory notes to ASE Test, Inc. in the principal amount of $2,000,000 (the "Principal Amount") and six percent (6%) compounded interest of which was due on March 13, 2025. On March 10, 2025, the Issuer and ASE Test, Inc. entered into an amendment to the 2023 Convertible Note (the "Amended Convertible Note") to extend the maturity date to March 12, 2027 and change the conversion price from $7.50 per share to a conversion price equal to the lower of (a) $7.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the noteholder exercises the conversion right or (y) $4.50, subject to anti-dilutive adjustment as set forth in the Amended Convertible Note.
表 II 有 1 筆交易的價格引用這則附註。
- F3
As a result of the five-for-one reverse stock split effected by the Issuer on June 30, 2025, the conversion price is now the lower of (a) $37.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the noteholder exercises the conversion right or (y) $22.50, subject to anti-dilutive adjustment as set forth in the Amended Convertible Note.
表 II 有 1 筆交易的價格引用這則附註。